Medical and Pharma Insider’s Post

In the ever-evolving pharmaceutical landscape, effective communication between biopharma companies and payers is essential. Cencora’s Alvana Maliqi, PharmD, MBA, Associate Director of Value and Access Strategy, is at the forefront of groundbreaking research on pre-approval information exchange (PIE) and on how biopharma manufacturers can utilize this information more efficiently. In an interview with Fierce Pharma, she shares how key strategies lead to successful product launches and payer communications: https://ow.ly/AfV350SBySi

Exploring the top 20 pharmaceutical companies by revenue for 2023, uncovering key industry insights and trends. #PharmaIndustry #MarketAnalysis

According to Grand View Research, the global pharmaceutical CDMO market was estimated at $146 billion in 2023 and is projected to grow at a CAGR of 7.2% from 2024 to 2030.   CDMOs play a crucial role in the development and manufacture of today’s drug products and continue to invest in providing specialized services and capabilities to meet the demands of today’s advanced therapies. In the recent edition of Contract Pharma, Jeff Clement discusses PCI Pharma Services global strategy to enhance sterile fill-finish capabilities and capacities. This includes the development of a new 50,000-square-foot multi-product facility, enabling the expansion of services as a global CDMO. The aim is to provide best-in-class late-stage clinical and commercial scale, fully isolated vial filling and lyophilization solutions to both new and existing clients. Read the full article and learn more about the key areas of investment and gain insight into recent sterile fill-finish and injectable packaging expansions to secure our client supply chains: https://lnkd.in/eJDvmMrs #CDMO #SterileFillFinish #PharmaManufacturing #LetsTalkFuture

The #Global #Joint #Pain #Injections #Market was valued at USD 4.88 billion in 2023.It is expected to reach USD 10.23 billion by 2030, with a #cagr of 9.36% during 2024-2030. The report analyses the market #by type, #application, #distribution channel, and #region, #offering insights on market #dynamics and competitive #assessment of major #players. BY : Read More Here : https://lnkd.in/epcBaFs9 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Sanofi, Zimmer Biomet, Bioventus LLC, Ferring Pharmaceuticals, Seikagaku Corporation, Anika Therapeutics Inc, Pfizer Inc, Flexion Therapeutics Inc, Teva Pharmaceutical Industries Ltd, Allergan plc. #trendingnow #marketforecast #research #researchanddevelopment #marketforecast #marketresearchreport #trendingpost #jointpain #jointpaininjectionmarket #market

Pharma Industry News Highlights 🌟💉 1. KBI Biopharma expands a $250M contract, extending its manufacturing partnership through 2029 and opening a new facility. 🏭📈 2. The FDA reviews Checkpoint Therapeutics Inc' BLA for cosibelimab, a potential treatment for metastatic cutaneous squamous cell carcinoma. 🏥🔬 3. QuVa Pharma, Inc. acquires LogicStream Health Inc., enhancing their analytics capabilities in pharmaceutical compounding. 📊🤝 4. Kobayashi Pharmaceutical Co., Ltd. faces reporting issues, raising concerns over regulatory compliance. 🚨⚖️ Stay informed with Pharma Now! Read more news at - https://lnkd.in/dh36nZ8Y What are your thoughts on these updates? Share your opinions in the comments below! 💬 #PharmaNow #pharmanews #healthcareinnovation #globalpharma #manufacturing #FDAreview #acquisitions #regulatorycompliance

🎥A Conversation with Acurx Pharmaceuticals' CEO 🎥 Join New to The Street's Jane King as she chats with David Luci , President/CEO of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) . Discover the latest insights from this late-stage biopharmaceutical company, publicly traded on the NASDAQ market. 💊📈 🔥Be sure to watch the full interview Today at 10:30pm PT on Fox Business Network. Click the link to read🔥🔥 https://lnkd.in/dHz-UX8C #acurxpharmaceuticals #wellness #health #healthcare #cure #medicine #pharmacy #science #businessupdate #businessnews #business #news #newtothestreet

Check out the latest insights from the Finnish, Norwegian, and Swedish Pharmaceutical Market Overviews for January 2024! The Finnish market saw a monthly growth of 10.3%, with Orion Pharma leading the top 10 health companies. Meanwhile, the Norwegian market experienced a growth of 20.9%, with Sandoz Pharma AS at the forefront. The Swedish market also showed promising growth at 13.4%, with B-Myers Squibb topping the list of health companies. Stay tuned for more updates! #PharmaceuticalMarket #HealthcareIndustry #MarketGrowth

Check out some news from two iBIO Members!

The Pharmaceutical CDMO market is evolving rapidly! With increasing demand for innovative therapies, pharmaceutical companies are turning to CDMOs for specialized development and manufacturing services. I've seen the difference a strong CDMO partnership can make—accelerating timelines and enhancing quality control. It’s all about choosing the right partner who understands your vision and can adapt to the fast-paced nature of drug development. As the industry grows, so do the opportunities for collaboration, innovation, and efficiency. Exciting times ahead for those in the healthcare space! What’s been your experience with CDMOs? Let’s connect and share insights! https://lnkd.in/dSmRYxpC Cambrex, Catalent Pharma Solutions, Labcorp, Lonza, Piramal Pharma Solutions, RECIPHARM OT CHEMISTRY AB, Samsung Biologics, SIEGFRIED HOLDING AG-REG, Thermo Fisher Scientific #Pharma #CDMO #HealthcareInnovation #DrugDevelopment #PharmaceuticalIndustry #Biotech #Partnerships

In an article on Q1 pharma earnings, MM+M included commentary from Citeline analyst Flora Mackay. She notes that Moderna’s full year net sales outlook represents a “considerable markdown” from 2023. Read it now: https://ow.ly/BQIE50SqUoL. #PharmaEarnings #BiotechNews #PharmaInsights #ModernaSales #HealthcareAnalysis